With Hemlibra, Roche seeks to break into tight hemophilia circle

Swiss drugmaker Roche is breaking into hemophilia A treatment, a $10 billion global market dominated by rivals who have cultivated close ties to sufferers of the genetic bleeding disorder.

from Reuters: Top News https://ift.tt/2DQwQRd